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CASE HISTORY
A man of 45 was referred having had four episodes of angiooedema of the lips over the previous four months. On each occasion the symptoms had resolved over a few hours and at least once had been associated with an area of urticaria. None of the episodes had followed the use of any medications, a particular food, an infection or exposure to heat, cold or sun. He had been treated in the accident and emergency department twice with corticosteroids and antihistamines and once with adrenaline. On the last occasion, the findings had included an area of urticaria on his left upper arm and a fading area on his forearm together with slight angio-oedema of the upper lip; levels of C1-esterase inhibitor had been normal. Regular antihistamines were prescribed for CUA.
On the present occasion the patient said that for the previous month he had been experiencing myalgia, heat intolerance, sweating, palpitations, lassitude and neck pain. On examination he had a tender, firm, smooth goitre, fine tremor, sinus tachycardia of 106/min and lid lag. Plasma thyroxine was 37.8 pmol/L (reference range 10.3-23.2), thyroid stimulating hormone (TSH) 50.1 mU/L (0.4-5.5), erythrocyte sedimentation rate (ESR) 28 mm/h (1-7), thyroglobulin (Tg) antibodies 7.1 U/mL (51) and thyroid peroxidase (Tp) antibodies 50.3 U/mL (50.3). A thyroid scan revealed no uptake of 99m-pertechnetate. SAT was diagnosed but no treatment was initiated. Two weeks later his thyroxine had dropped to 28.2 pmol/L and he was symptomatically better; the thyroid was no longer palpable or tender and his pulse rate was 80/min, though he still had some action tremor and was heat intolerant. At eight weeks he became subclinically hypothyroid, with thyroxine 11.2 pmol/L and TSH 10.1 mU/L; he was still excessively tired. At five months he had a further episode of angiooedema, at which time thyroxine was 9.7 pmol/L and TSH 3.1 mU/L; he had no symptoms related to his thyroid. One week later thyroxine was 11.9 pmol/L and TSH 3.5 mU/L. Twelve months after initial presentation he was clinically and biochemically euthyroid, with thyroxine 12 pmol/L, TSH 4.1 mU/L, ESR 2, thyroglobulin antibodies 1.2 U/mL and thyroid peroxidase antibodies 50.3 U/mL. There had been no further episodes of angio-oedema or urticaria.
COMMENT CUA is arbitrarily defined as episodes of urticaria and angiooedema lasting longer than six weeks. Often no cause is found. The presence of thyroid antibodies in 12-29% of patients with CUA compared with 4% of the general population [1] [2] [3] suggests an autoimmune origin in a subgroup of patients. In one study autoimmune thyroid disease was detected in 6% of these patients-a higher frequency than in controls. 2 In addition, 30% of CUA patients have a circulating IgG antibody against the high affinity IgE receptor. 4 Subacute thyroiditis typically presents with a brief thyrotoxic illness associated with a tender thyroid gland with no uptake on a thyroid scan. Often a longer hypothyroid phase ensues before resolution to normal thyroid function. The cause of SAT is likewise unknown, although at least 40% of cases seem to be postviral. 5 10-20% of patients with SAT have moderately raised thyroglobulin antibodies, which drop when the disease resolves (as in the present case), again suggesting an autoimmune aetiology in a subgroup of patients. As far as we are aware there is no previous case report of CUA and SAT occurring simultaneously.
Thyroxine has been used in patients with CUA and thyroid autoimmunity, 3 but this is not widely accepted. 7 In the patient presented here, the short-lasting decrease in thyroxine associated with an episode of angio-oedema could represent the sick euthyroid syndrome or an interaction between the two disease processes, though more likely it simply reflects part of the recovery phase of thyroiditis. There is reason to think that the two diseases in this patient are linked by an autoimmune mechanism, but we cannot exclude the possibility that their association was fortuitous. When pulmonary hypertension develops in the presence of connective tissue disease, it may be reversible by prompt immunosuppressive therapy.
A previously fit man of 46 reported six months of fatigue, ankle swelling, numbness in the feet and dyspnoea on mild exertion. He had never smoked. On examination he had moderate gynaecomastia and there were several 6 mm nodules on the anterior chest wall. He was in right heart failure, with a parasternal heave and a loud pulmonary component of the second heart sound. Additional abnormalities were ascites, 5 cm splenomegaly, loss of light touch and vibration sense in the lower limbs (with absent ankle jerks), and papilloedema. 1 mU/L, free T3 6.9 pmol/L)). A chest X-ray was normal, as were CT and MRI of the brain. Cerebrospinal fluid protein was slightly raised at 1.1 g/L and nerve conduction studies pointed to a demyelinating sensorimotor neuropathy. Echocardiography showed pulmonary artery hypertension (systolic pressure 40 mmHg) and right ventricular hypertrophy. On histological examination, a skin lesion was seen to contain several glomeruloid haemangiomata. This conjunction of abnormalities fulfilled the criteria for POEMS (polyneuropathy-organomegalyendocrinopathy-M band-skin changes) syndrome. Cardiac catheterization confirmed the pulmonary arterial hypertension. Acute administration of Iloprost (epoprostenol) reduced pulmonary vascular resistance by 57% ( Table 1) . The patient was started on warfarin and a calcium channel antagonist in high dosage. Immunosuppressive therapy for the POEMS was prednisolone 30 mg and azathioprine 150 mg daily. Testosterone and thyroxine replacement was also initiated. The calcium channel antagonist had to be stopped because of intolerance. After ten months on this regimen he had improved clinically. However, when the azathioprine was withheld because of nausea and vomiting there was a recurrence of ascites, ankle swelling and dyspnoea. Immunosuppression was reintroduced with mycophenolate mofetil 1 g twice daily and prednisolone 30 mg daily, to which he responded with full resolution of the decompensation. Repeat right heart catheterization three months later showed haemodynamic improvement with mean pulmonary artery pressure 25 mmHg (Table 1) . 3 years after the original diagnosis of pulmonary arterial hypertension, and still taking mycophenolate mofetil and prednisolone, the patient remains well with good exercise tolerance.
COMMENT POEMS or Crow-Fukase syndrome is a multisystem disorder first defined by Nikanishi et al. 1 Recently, Miralles et al. 2 studied 2714 cases and showed that this syndrome is indistinguishable from the rare variant of osteosclerotic myeloma with polyneuropathy. Overproduction of proinflammatory cytokines and the endothelial-cell-specific mitogen and potent angiogenic peptide vascular endothelial growth factor (VEGF) has been demonstrated. 3 The expression of VEGF in glomeruloid lesions of the skin and kidney in POEMS is noteworthy since similar expression has been reported in plexiform lesions of other patients with pulmonary arterial hypertension. In our
